- Home
- SQNS vs VRCA Comparison
SQNS vs VRCA Comparison
Compare SQNS & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQNS
- VRCA
- Stock Information
- Founded
- SQNS 2003
- VRCA 2013
- Country
- SQNS France
- VRCA United States
- Employees
- SQNS N/A
- VRCA N/A
- Industry
- SQNS Semiconductors
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- SQNS Technology
- VRCA Health Care
- Exchange
- SQNS Nasdaq
- VRCA Nasdaq
- Market Cap
- SQNS 46.5M
- VRCA 65.4M
- IPO Year
- SQNS 2011
- VRCA 2018
- Fundamental
- Price
- SQNS $4.52
- VRCA $0.81
- Analyst Decision
- SQNS Strong Buy
- VRCA Hold
- Analyst Count
- SQNS 1
- VRCA 5
- Target Price
- SQNS $7.50
- VRCA $6.00
- AVG Volume (30 Days)
- SQNS 9.6M
- VRCA 775.3K
- Earning Date
- SQNS 08-22-2025
- VRCA 08-13-2025
- Dividend Yield
- SQNS N/A
- VRCA N/A
- EPS Growth
- SQNS N/A
- VRCA N/A
- EPS
- SQNS 2.16
- VRCA N/A
- Revenue
- SQNS $38,858,000.00
- VRCA $7,179,000.00
- Revenue This Year
- SQNS N/A
- VRCA $171.87
- Revenue Next Year
- SQNS $93.87
- VRCA $71.38
- P/E Ratio
- SQNS $1.81
- VRCA N/A
- Revenue Growth
- SQNS 40.06
- VRCA N/A
- 52 Week Low
- SQNS $0.95
- VRCA $0.38
- 52 Week High
- SQNS $5.50
- VRCA $8.98
- Technical
- Relative Strength Index (RSI)
- SQNS 87.95
- VRCA 70.98
- Support Level
- SQNS $1.34
- VRCA $0.77
- Resistance Level
- SQNS $2.68
- VRCA $0.67
- Average True Range (ATR)
- SQNS 0.52
- VRCA 0.08
- MACD
- SQNS 0.29
- VRCA 0.03
- Stochastic Oscillator
- SQNS 76.77
- VRCA 81.85
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.